Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer

por Christoph, F, Kempkensteffen, C, Weikert, S, Köllermann, J, Krause, H, Miller, K, Schostak, M, Schrader, M
Publicado 2006

The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer

por Beresford, M J, Harris, A L, Ah-See, M, Daley, F, Padhani, A R, Makris, A
Publicado 2006

Three-week schedule of irinotecan plus cisplatin in patients with previously untreated extensive-stage small-cell lung cancer

por Hong, Y S, Lee, H R, Park, S, Lee, S C, Hwang, I G, Park, B-B, Lee, J, Ahn, J S, Ahn, M-J, Lim, H Y, Park, K
Publicado 2006

The status of CDKN2A alpha (p16(INK4A)) and beta (p14(ARF)) transcripts in thyroid tumour progression

por Ferru, A, Fromont, G, Gibelin, H, Guilhot, J, Savagner, F, Tourani, J M, Kraimps, J L, Larsen, C J, Karayan-Tapon, L
Publicado 2006

Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer

por Mochiki, E, Ohno, T, Kamiyama, Y, Aihara, R, Haga, N, Ojima, H, Nakamura, J, Ohsawa, H, Nakabayashi, T, Takeuchi, K, Asao, T, Kuwano, H
Publicado 2006

Factors associated with emotional and behavioural problems among school age children of breast cancer patients

por Watson, M, St. James-Roberts, I, Ashley, S, Tilney, C, Brougham, B, Edwards, L, Baldus, C, Romer, G
Publicado 2006

Adiponectin in relation to childhood myeloblastic leukaemia

por Petridou, E, Mantzoros, C S, Dessypris, N, Dikalioti, S K, Trichopoulos, D
Publicado 2006

Time and chemotherapy treatment trends in the treatment of elderly patients (age ⩾70 years) with small cell lung cancer

por Yau, T, Ashley, S, Popat, S, Norton, A, Matakidou, A, Coward, J, O'Brien, M E R
Publicado 2006

Current management of treatment-induced bone loss in women with breast cancer treated in the United Kingdom

por Lester, J E, Dodwell, D, Horsman, J M, Mori, S, Coleman, R E
Publicado 2006

Mechanistic mathematical modelling of mercaptopurine effects on cell cycle of human acute lymphoblastic leukaemia cells

por Panetta, J C, Evans, W E, Cheok, M H
Publicado 2006

Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence

por Barnes, N, Haywood, P, Flint, P, Knox, W F, Bundred, N J
Publicado 2006

BRAF mutations and phosphorylation status of mitogen-activated protein kinases in the development of flat and depressed-type colorectal neoplasias

por Konishi, K, Takimoto, M, Kaneko, K, Makino, R, Hirayama, Y, Nozawa, H, Kurahashi, T, Kumekawa, Y, Yamamoto, T, Ito, H, Yoshikawa, N, Kusano, M, Nakayama, K, Rembacken, B J, Ota, H, Imawari, M
Publicado 2006

Determination of TGFβ1 protein level in human primary breast cancers and its relationship with survival

por Desruisseau, S, Palmari, J, Giusti, C, Romain, S, Martin, P-M, Berthois, Y
Publicado 2006

Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer

por Stockler, M R, Tattersall, M H N, Boyer, M J, Clarke, S J, Beale, P J, Simes, R J
Publicado 2006

PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer

por Fujita, T, Doihara, H, Kawasaki, K, Takabatake, D, Takahashi, H, Washio, K, Tsukuda, K, Ogasawara, Y, Shimizu, N
Publicado 2006

Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study

por Verkooijen, H M, Chappuis, P O, Rapiti, E, Vlastos, G, Fioretta, G, Sarp, S, Sappino, A P, Schubert, H, Bouchardy, C
Publicado 2006

Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy

por Manton, D J, Chaturvedi, A, Hubbard, A, Lind, M J, Lowry, M, Maraveyas, A, Pickles, M D, Tozer, D J, Turnbull, L W
Publicado 2006

Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma

por Jones, R L, Lakhani, S R, Ring, A E, Ashley, S, Walsh, G, Smith, I E
Publicado 2006

Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study

por Demols, A, Peeters, M, Polus, M, Marechal, R, Gay, F, Monsaert, E, Hendlisz, A, Van Laethem, J L
Publicado 2006

Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival

por Ino, K, Shibata, K, Kajiyama, H, Yamamoto, E, Nagasaka, T, Nawa, A, Nomura, S, Kikkawa, F
Publicado 2006